Medirom Healthcare Files 6-K with Q2 2025 Financial Data
Ticker: MRM · Form: 6-K · Filed: Oct 21, 2025 · CIK: 1819704
Sentiment: neutral
Topics: financial-update, foreign-issuer, quarterly-data
TL;DR
Medirom Healthcare dropped Q2 2025 financials in a 6-K, showing stock and retained earnings data.
AI Summary
Medirom Healthcare Technologies Inc. filed a 6-K report for the period ending June 30, 2025. The filing includes financial data such as Additional Paid-In Capital, Common Stock, Treasury Stock, Retained Earnings, and Noncontrolling Interest for various periods in 2023, 2024, and 2025. The company is based in Tokyo, Japan.
Why It Matters
This filing provides investors with updated financial information for Medirom Healthcare Technologies Inc., allowing them to assess the company's financial health and performance during the second quarter of 2025.
Risk Assessment
Risk Level: low — This is a routine financial filing (6-K) that provides updated financial data and does not indicate any immediate or significant risks.
Key Numbers
- 2025-06-30 — Reporting Period End Date (The filing covers financial data up to this date for Q2 2025.)
- 2025-10-21 — Filing Date (The date the 6-K report was submitted to the SEC.)
Key Players & Entities
- Medirom Healthcare Technologies Inc. (company) — Filer of the report
- 0001819704 (company) — Central Index Key for Medirom Healthcare Technologies Inc.
- Tokyo (location) — Business and mailing address of the company
FAQ
What specific financial figures are detailed in the filing for Q2 2025?
The filing details figures for Additional Paid-In Capital, Common Stock, Treasury Stock, Retained Earnings, and Noncontrolling Interest as of June 30, 2025.
What is the company's fiscal year end?
Medirom Healthcare Technologies Inc.'s fiscal year ends on December 31.
Where is Medirom Healthcare Technologies Inc. located?
The company's business and mailing addresses are in Tokyo, Japan.
What type of SEC filing is this?
This is a Form 6-K, which is a report of foreign private issuers regarding information made available to the public in their home country.
What is the SEC file number for this filing?
The SEC file number is 001-39809.
Filing Stats: 290 words · 1 min read · ~1 pages · Grade level 12.8 · Accepted 2025-10-21 17:24:50
Filing Documents
- mrm-20250630x6k.htm (6-K) — 124KB
- mrm-20250630xex99d1.htm (EX-99.1) — 1694KB
- mrm-20250630xex99d1001.jpg (GRAPHIC) — 5KB
- mrm-20250630xex99d1002.jpg (GRAPHIC) — 62KB
- 0001104659-25-101302.txt ( ) — 8608KB
- mrm-20250630.xsd (EX-101.SCH) — 56KB
- mrm-20250630_cal.xml (EX-101.CAL) — 81KB
- mrm-20250630_def.xml (EX-101.DEF) — 213KB
- mrm-20250630_lab.xml (EX-101.LAB) — 473KB
- mrm-20250630_pre.xml (EX-101.PRE) — 341KB
- mrm-20250630x6k_htm.xml (XML) — 1750KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Date: October 21, 2025 By: /s/ Fumitoshi Fujiwara Name: Fumitoshi Fujiwara Title: Chief Financial Officer